Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - caspofungin acetate, quantity: 77.7 mg (equivalent: caspofungin, qty 70 mg) - injection, powder for - excipient ingredients: sodium hydroxide; sucrose; hydrochloric acid; mannitol - caspofungin amneal is indicated for:,? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics,? treatment of:,-invasive candidiasis, including candidaemia,-oesophageal candidiasis,-invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - caspofungin acetate, quantity: 55.5 mg (equivalent: caspofungin, qty 50 mg) - injection, powder for - excipient ingredients: sodium hydroxide; mannitol; sucrose; hydrochloric acid - caspofungin kp is indicated for:,? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics,? treatment of:,-invasive candidiasis, including candidaemia,-oesophageal candidiasis,-invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - caspofungin acetate, quantity: 77.7 mg (equivalent: caspofungin, qty 70 mg) - injection, powder for - excipient ingredients: hydrochloric acid; mannitol; sodium hydroxide; sucrose - caspofungin ch is indicated for:,? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics,? treatment of:,-invasive candidiasis, including candidaemia,-oesophageal candidiasis,-invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - caspofungin acetate, quantity: 77.69 mg (equivalent: caspofungin, qty 70 mg) - injection, powder for - excipient ingredients: sucrose; mannitol; glacial acetic acid; sodium hydroxide - caspofungin cipla is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - caspofungin acetate, quantity: 55.49 mg (equivalent: caspofungin, qty 50 mg) - injection, powder for - excipient ingredients: sucrose; mannitol; glacial acetic acid; sodium hydroxide - caspofungin cipla is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - caspofungin acetate, quantity: 77.69 mg (equivalent: caspofungin, qty 70 mg) - injection, powder for - excipient ingredients: sucrose; mannitol; glacial acetic acid; sodium hydroxide - caspofungin ca is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - caspofungin acetate, quantity: 55.49 mg (equivalent: caspofungin, qty 50 mg) - injection, powder for - excipient ingredients: sucrose; mannitol; glacial acetic acid; sodium hydroxide - caspofungin ca is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - caspofungin acetate eqv caspofungin - injection, powder, for solution - 50 mg - caspofungin acetate eqv caspofungin 50 mg/vial

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - caspofungin acetate eqv caspofungin - injection, powder, for solution - 70 mg/vial - caspofungin acetate eqv caspofungin 70 mg/vial

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - caspofungin acetate, quantity: 55.5 mg (equivalent: caspofungin, qty 50 mg) - injection, powder for - excipient ingredients: sucrose; mannitol; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - cancigin is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.